Sign in to continue:

Tuesday, April 14th, 2026

Bio Green Med Solution, Inc. Files Form 8-K with SEC – Company Details, Nasdaq Listing, and Contact Information (April 2026)

Bio Green Med Solution, Inc. Declares Dividend on 6% Convertible Exchangeable Preferred Stock

Bio Green Med Solution, Inc. (NASDAQ: BGMS) has announced a significant development that could impact its share price and is highly relevant to both current and prospective investors.

Key Highlights from the Report

  • Dividend Declaration: On April 13, 2026, the Board of Directors declared a quarterly cash dividend of \$0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock.
  • Record and Payment Dates: The dividend will be paid on May 1, 2026, to all holders of the Preferred Stock as of the close of business on April 23, 2026.
  • Class of Security Impacted: This dividend relates specifically to the 6% Convertible Exchangeable Preferred Stock, not the common stock.

Details Investors and Shareholders Should Note

  • Potential Share Price Impact: The announcement of a cash dividend may positively impact the share price of the Preferred Stock, as it reflects the company’s ongoing ability to return value to shareholders and its financial health.
  • Ongoing Income Stream: Holders of the Preferred Stock will receive a steady quarterly income, which can make the security more attractive compared to non-dividend-paying alternatives.
  • Convertible and Exchangeable Features: The Preferred Stock in question is both convertible and exchangeable, giving investors additional flexibility and potential upside if the common shares appreciate in value.
  • Shareholder Record Date: Investors must be on record as of April 23, 2026, to receive the dividend. Any transactions after this date will not impact eligibility for this dividend payment.
  • Stock Exchange and Trading Symbol: Bio Green Med Solution, Inc.’s common stock is listed on the NASDAQ Capital Market under the ticker symbol BGMS.
  • Emerging Growth Company Status: The company has indicated it is not an emerging growth company, which may indicate maturity in its reporting and operational profile.

Other Considerations

  • No Simultaneous Filings: The company stated that this Form 8-K does not simultaneously satisfy any written communications, soliciting material, or pre-commencement tender offer obligations.
  • Corporate Information:

    • SEC CIK: 0001130166
    • State of Incorporation: Delaware (DE)
    • SEC File Number: 0-50626
    • Tax Identification Number: 91-1707622
  • Security Details:

    • Common Stock, par value \$0.001 per share
    • Trading Symbol: BGMS
    • Exchange: NASDAQ

Implications for Shareholders and Potential Investors

The quarterly dividend declaration is a positive signal about Bio Green Med Solution, Inc.’s financial stability and commitment to returning value to shareholders. This news may lead to increased interest in the preferred shares and potentially affect the company’s stock price. Investors should consider the record and payment dates for eligibility and the features of the preferred stock when making investment decisions.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with a qualified financial advisor before making investment decisions. The information provided is based on official SEC filings and public disclosures as of the date noted.

View Bio Green Med Solution, Inc. Historical chart here



   Ad